Substitution of nevirapine because of efavirenz toxicity in AIDS clinical trials group A5095.

Schouten JT, Krambrink A, Ribaudo HJ, Kmack A, Webb N, Shikuma C, Kuritzkes DR, Gulick RM. Substitution of nevirapine because of efavirenz toxicity in AIDS clinical trials group A5095. Clin Infect Dis. 2010 Mar 01; 50(5):787-91.

View in: PubMed

subject areas

Acquired Immunodeficiency Syndrome
Adult
Alkynes
Antiviral Agents
Benzoxazines
Cyclopropanes
Female
Humans
Liver
Male
Middle Aged
Nevirapine
Withholding Treatment

authors with profiles

Cecilia M. Shikuma,MD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support